6-Methoxypyrido[3,4-d]pyrimidin-4(1H)-one
97%
- Product Code: 211922
CAS:
183741-98-2
| Molecular Weight: | 177.16 g./mol | Molecular Formula: | C₈H₇N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry |
Product Description:
Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceutical research targeting cancer therapies. Its structure enables selective binding to enzyme active sites, making it valuable in developing drugs that modulate cell signaling pathways. Commonly employed in the preparation of compounds with antitumor and anti-inflammatory activities. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50mg | 10-20 days | ฿2,050.00 |
+
-
|
| 100mg | 10-20 days | ฿4,060.00 |
+
-
|
| 1g | 10-20 days | ฿35,180.00 |
+
-
|
| 250mg | 10-20 days | ฿10,120.00 |
+
-
|
6-Methoxypyrido[3,4-d]pyrimidin-4(1H)-one
Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceutical research targeting cancer therapies. Its structure enables selective binding to enzyme active sites, making it valuable in developing drugs that modulate cell signaling pathways. Commonly employed in the preparation of compounds with antitumor and anti-inflammatory activities. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :